Entegris (ENTG) Q1 2025 earnings summary

Executive summary

• Q1 2025 net sales were $773.2 million, up 0.3% year-over-year (5% adjusted, excluding divestitures), with gross margin, EBITDA margin, and non-GAAP EPS at the midpoint of guidance.

• Net income rose to $62.9 million, up 39% year-over-year, driven by improved plant performance and absence of prior-year impairment and debt extinguishment charges.

• Material solutions sales rose 8% year-over-year, driven by CMP slurries and pads, while advanced purity solutions increased 3% year-over-year, led by micro contamination control.

• The company completed the divestiture of the PIM business in Q1 2024, impacting year-over-year comparisons.

• Management is prioritizing cost control, free cash flow improvement, and debt reduction amid industry and tariff uncertainties.

Financial highlights

• Gross margin was 46.1% (GAAP and non-GAAP), up from 45.6% year-over-year, with adjusted EBITDA margin at 28.5%.

• GAAP net income for Q1 2025 was $62.9 million, up 38.9% year-over-year; diluted GAAP EPS was $0.41, non-GAAP EPS $0.67.

• Operating income reached $122.3 million, with an operating margin of 15.8%.

• Net cash from operating activities was $140.4 million; capital expenditures were $108 million.

• Ending cash balance was $340.9 million; long-term debt stood at $3,984.5 million.

Outlook and guidance

• Q2 2025 sales guidance is $735–$775 million, with GAAP net income forecasted at $51–$62 million and non-GAAP EPS at $0.60–$0.67.

• Adjusted EBITDA margin for Q2 2025 expected to be ~27.5%; adjusted operating margin guidance: 20.4%–22.1%.

• Broader revenue guidance reflects uncertainty from China tariffs; no update to full-year 2025 outlook.

• Management expects continued impact from global trade tensions and tariffs, particularly affecting U.S.-manufactured products sold to China.

• Liquidity and cash flow are considered sufficient for the next twelve months and longer term.